Special Issue "Public Psychobehavioral Responses towards Vaccination"
Deadline for manuscript submissions: 30 April 2024 | Viewed by 11824
This Special Issue focuses on identifying important gaps in psychological and behavioral responses, exclusively focusing on, but not limited to, COVID-19 vaccination. Since the Food and Drug Administration (FDA) gave its full approval of the first COVID-19 vaccine, there has been an exponential growth in the number of publications on studies assessing the psychological and behavioral responses to COVID-19 vaccination throughout the world. Psychobehavioral responses to COVID-19 vaccination differ in people from specific cultures and countries. There are huge variations in the psychobehavioral responses to COVID-19 vaccination between countries, and even within them. Despite the large number of publications, significant information gaps still exist. Particularly, there has been a scarcity of studies conducted on neglected or marginalized populations. People living in poverty as well as vulnerable populations in society throughout the world are heavily burdened during the pandemic. There is still much to learn about their vaccination rates, vaccine acceptance, and respective psychobehavioral responses.
From the onset of the COVID-19 pandemic, much vaccine acceptance research has focused almost exclusively around COVID-19 vaccines. Throughout the pandemic, governments have implemented a variety of containment measures that impact the uptake of other vaccines and resulted in a reduction in routine immunization coverage. Relatively little has been published on vaccine coverage for other diseases, such as influenza, cervical cancer, cholera, diphtheria, hepatitis B, influenza, measles, and polio. Additionally, the intention to get other vaccines may likely modify during the pandemic. There is still an incomplete understanding of how the pandemic has altered people's trust in other vaccines. Vaccines are the cornerstone of the management of many infectious disease outbreaks. As nations struggle to control the COVID-19 pandemic, hesitancy against a vaccine that protects from other infectious diseases may potentially result in another disease outbreak during the COVID-19 pandemic. More evidence is warranted to provide a better understanding of the effects of the COVID-19 pandemic on the hesitancy linked to other vaccines to implement early corrective actions.
In short, vaccine hesitancy is a major barrier to vaccine uptake and the achievement of herd immunity. Understanding the psychobehavioral responses to vaccination is important to promote vaccine uptake. This Special Issue aims to gather an extensive understanding of the psychobehavioral response to all types of vaccines. Owing to your extensive knowledge and previous research experience, we invite you to contribute with an original report, or review, to highlight various aspects of psychological and behavioral responses to COVID-19 as well as other infectious disease vaccinations.
Prof. Dr. Li Ping Wong
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- vaccine hesitancy